Lori M. Henderson - May 11, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
General Counsel and Secretary
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
May 11, 2021
Transactions value $
-$898,022
Form type
4
Date filed
5/13/2021, 04:05 PM
Previous filing
May 7, 2021
Next filing
May 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $9K +430 +47.72% $20.93* 1.33K May 11, 2021 Direct F1
transaction MRNA Common Stock Options Exercise $91.6K +6.17K +463.56% $14.85* 7.5K May 11, 2021 Direct F1
transaction MRNA Common Stock Sale -$999K -6.6K -87.99% $151.31 901 May 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -430 -0.46% $0.00 93K May 11, 2021 Common Stock 430 $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -6.17K -1.68% $0.00 361K May 11, 2021 Common Stock 6.17K $14.85 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
F2 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3 25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in twelve (12) equal quarterly installments thereafter.